Ocular Therapeutix, Inc. (OCUL)Healthcare | Biotechnology | Bedford, United States | NasdaqGM
9.82 USD
+0.96
(10.835%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 9.80 -0.02 (-0.020%) ⇩ (April 17, 2026, 7:13 p.m. EDT) Short-term: ★★★☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:55 a.m. EDT
Despite analyst 'Strong Buy' ratings, the fundamentals are severely distressed with negative revenue growth (-22.4%), negative gross and operating margins, and a negative free cash flow. The stock has recently reversed a prior decline to reset near recent lows, but the lack of a dividend and deteriorating economic metrics keep it in the 'weak' long-term category until revenue profitability is proven. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.180144 |
| AutoARIMA | 0.207442 |
| AutoETS | 0.207442 |
| AutoTheta | 0.234642 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.95 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.985 |
| Excess Kurtosis | 0.09 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 11.763 |
| Revenue per Share | 0.277 |
| Market Cap | 2,137,733,120 |
| Forward P/E | -7.82 |
| Beta | 0.95 |
| Website | https://www.ocutx.com |
As of April 19, 2026, 12:55 a.m. EDT: Options market shows heightened volatility risk with premium implicit volatility (IV) spikes at low strikes (e.g., $1 OTM for calls, $2.5 for puts) indicating a need for volatility insurance against significant price moves. Open Interest (OI) walls are prominent near the current price ($10–$12 strike), with call OI exceeding put OI in June and September, suggesting speculative bullish positioning for upside, though sell warrants in lower-dated weeks remain hidden in the data.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.2904073 |
| Address1 | 15 Crosby Drive |
| All Time High | 44.19 |
| All Time Low | 1.995 |
| Ask | 9.85 |
| Ask Size | 8 |
| Audit Risk | 5 |
| Average Analyst Rating | 1.4 - Strong Buy |
| Average Daily Volume10 Day | 3,507,300 |
| Average Daily Volume3 Month | 5,803,138 |
| Average Volume | 5,803,138 |
| Average Volume10Days | 3,507,300 |
| Beta | 0.952 |
| Bid | 9.79 |
| Bid Size | 8 |
| Board Risk | 7 |
| Book Value | 3.03 |
| City | Bedford |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 10 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 9.82 |
| Current Ratio | 15.394 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 9.86 |
| Day Low | 9.01 |
| Debt To Equity | 11.763 |
| Display Name | Ocular Therapeutix |
| Earnings Call Timestamp End | 1,762,261,200 |
| Earnings Call Timestamp Start | 1,762,261,200 |
| Earnings Timestamp | 1,770,298,200 |
| Earnings Timestamp End | 1,777,984,200 |
| Earnings Timestamp Start | 1,777,984,200 |
| Ebitda | -265,694,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -5.561 |
| Enterprise To Revenue | 28.443 |
| Enterprise Value | 1,477,641,216 |
| Eps Current Year | -1.3975 |
| Eps Forward | -1.256 |
| Eps Trailing Twelve Months | -1.42 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 8.8249 |
| Fifty Day Average Change | 0.9951 |
| Fifty Day Average Change Percent | 0.11276049 |
| Fifty Two Week Change Percent | 29.04073 |
| Fifty Two Week High | 16.44 |
| Fifty Two Week High Change | -6.620001 |
| Fifty Two Week High Change Percent | -0.40267643 |
| Fifty Two Week Low | 6.23 |
| Fifty Two Week Low Change | 3.5899997 |
| Fifty Two Week Low Change Percent | 0.57624394 |
| Fifty Two Week Range | 6.23 - 16.44 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,406,295,000,000 |
| Float Shares | 215,406,015 |
| Forward Eps | -1.256 |
| Forward P E | -7.818471 |
| Free Cashflow | -128,276,496 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 325 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | -2.92043 |
| Gross Profits | -151,719,008 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.01359 |
| Held Percent Institutions | 0.90299004 |
| Implied Shares Outstanding | 217,691,779 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing AXPAXLI, an axitinib intravitreal hydrogel that is in phase 3 clinical trials for the treatment of wet age-related macular degeneration and non-proliferative diabetic retinopathy; OTX-TIC, a travoprost intracameral hydrogel, which has completed phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension. The company has a license agreement and collaboration with AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts. |
| Long Name | Ocular Therapeutix, Inc. |
| Market | us_market |
| Market Cap | 2,137,733,120 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_41955650 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -265,939,008 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 2,137,733,269 |
| Number Of Analyst Opinions | 11 |
| Open | 9.01 |
| Operating Cashflow | -204,883,008 |
| Operating Margins | -5.26491 |
| Overall Risk | 10 |
| Payout Ratio | 0.0 |
| Phone | 781 357 4000 |
| Post Market Change | -0.019999504 |
| Post Market Change Percent | -0.20366095 |
| Post Market Price | 9.8 |
| Post Market Time | 1,776,467,636 |
| Previous Close | 8.86 |
| Price Eps Current Year | -7.026833 |
| Price Hint | 2 |
| Price To Book | 3.2409241 |
| Price To Sales Trailing12 Months | 41.14903 |
| Profit Margins | 0.0 |
| Quick Ratio | 15.111 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.36364 |
| Region | US |
| Regular Market Change | 0.96 |
| Regular Market Change Percent | 10.8352 |
| Regular Market Day High | 9.86 |
| Regular Market Day Low | 9.01 |
| Regular Market Day Range | 9.01 - 9.86 |
| Regular Market Open | 9.01 |
| Regular Market Previous Close | 8.86 |
| Regular Market Price | 9.82 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 5,316,554 |
| Return On Assets | -0.26661 |
| Return On Equity | -0.54852 |
| Revenue Growth | -0.224 |
| Revenue Per Share | 0.277 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 217,691,779 |
| Shares Percent Shares Out | 0.1157 |
| Shares Short | 25,192,853 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 17,648,381 |
| Short Name | Ocular Therapeutix, Inc. |
| Short Percent Of Float | 0.1161 |
| Short Ratio | 5.04 |
| Source Interval | 15 |
| State | MA |
| Symbol | OCUL |
| Target High Price | 34.0 |
| Target Low Price | 18.0 |
| Target Mean Price | 26.0 |
| Target Median Price | 27.0 |
| Total Cash | 737,059,968 |
| Total Cash Per Share | 3.386 |
| Total Debt | 76,968,000 |
| Total Revenue | 51,951,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.42 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 11.09935 |
| Two Hundred Day Average Change | -1.2793503 |
| Two Hundred Day Average Change Percent | -0.11526353 |
| Type Disp | Equity |
| Volume | 5,316,554 |
| Website | https://www.ocutx.com |
| Zip | 1,730 |